These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 2730451)

  • 21. Local delivery of mitoxantrone for the treatment of malignant brain tumors in rats.
    Broggi G; Ferroli P; Franzini A; Silvani A; Salmaggi A; Eoli M; Boiardi A
    J Neurosurg; 2003 Apr; 98(4):935-6; author reply 936. PubMed ID: 12691429
    [No Abstract]   [Full Text] [Related]  

  • 22. Mitoxantrone salvage in heavily pretreated advanced breast cancer.
    Nathanson L; Williams ME
    Prog Clin Biol Res; 1987; 248():283-7. PubMed ID: 3671416
    [No Abstract]   [Full Text] [Related]  

  • 23. [Mitoxantrone, a new reality].
    Ruiz-Peña JL; Izquierdo G
    Rev Neurol; 2003 Apr 1-15; 36(7):698-9. PubMed ID: 12666055
    [No Abstract]   [Full Text] [Related]  

  • 24. [Evaluation of mitoxantrone in 1989].
    Coiffier B
    Pathol Biol (Paris); 1989 Nov; 37(9):1007-8. PubMed ID: 2691971
    [No Abstract]   [Full Text] [Related]  

  • 25. Mitoxantrone and GM-CSF: a phase I study with an escalated dose of mitoxantrone in breast cancer.
    ten Bokkel Huinink WW; Clavel M; Rodenhuis S; Guastalla JP; Franklin HR; Koier JJ; Vlasveld T; Dalesio O; van Tinteren H; Pinedo HM
    Pathol Biol (Paris); 1992 Nov; 39(9):962. PubMed ID: 1538954
    [No Abstract]   [Full Text] [Related]  

  • 26. [Phase II study of mitoxantrone].
    Tada A; Ogawa M; Usui N; Inagaki J; Horikoshi N; Inoue K; Ikeda K; Adachi K; Nakada H; Okada Y
    Gan To Kagaku Ryoho; 1984 Aug; 11(8):1649-54. PubMed ID: 6476838
    [TBL] [Abstract][Full Text] [Related]  

  • 27. First-line mitoxantrone chemotherapy for advanced breast cancer.
    Wilson KS; Paterson AH
    Cancer Treat Rep; 1986 Aug; 70(8):1021-2. PubMed ID: 3731148
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation between experimentally and clinically demonstrated activity of two new cytotoxic agents in breast cancer.
    Bailey MJ; Smith IE
    Anticancer Res; 1985; 5(4):419-22. PubMed ID: 3839994
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rationale for the use of mitoxantrone in the older patient: cardiac toxicity.
    Benjamin RS
    Semin Oncol; 1995 Feb; 22(1 Suppl 1):11-3. PubMed ID: 7863345
    [No Abstract]   [Full Text] [Related]  

  • 30. Redox cycling in MCF-7 human breast cancer cells by antitumor agents based on mitozantrone.
    Fisher GR; Brown JR; Patterson LH
    Free Radic Res Commun; 1989; 7(3-6):221-6. PubMed ID: 2555276
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunity during monochemotherapy with mitoxantrone: preliminary results.
    Cartei G; Contessi E; Comelli M; Turrin D; Toso C; Sibau A; Mian S; Bramezza M
    J Chemother; 1989 Jul; 1(4 Suppl):1309-10. PubMed ID: 16312879
    [No Abstract]   [Full Text] [Related]  

  • 32. Mitoxantrone-loaded BSA nanospheres and chitosan nanospheres for local injection against breast cancer and its lymph node metastases. I: Formulation and in vitro characterization.
    Lu B; Xiong SB; Yang H; Yin XD; Zhao RB
    Int J Pharm; 2006 Jan; 307(2):168-74. PubMed ID: 16316729
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Mitoxantrone].
    Pericot I; Montalban X
    Neurologia; 2003; 18(6):318-23. PubMed ID: 12838451
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical and histological study on breast cancer treated by preoperative mitoxantrone].
    Meng ZX
    Zhonghua Zhong Liu Za Zhi; 1990 Jul; 12(4):294-6. PubMed ID: 2272266
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mitroxantrone in multiple sclerosis.
    Aggarwal S
    Neurol India; 2009; 57(6):837. PubMed ID: 20139539
    [No Abstract]   [Full Text] [Related]  

  • 36. Mitoxantrone as single agent in the treatment of advanced breast cancer: clinical experience at Siriraj Hospital.
    Tepmongkol P; Suphaphongs N; Thansakul A; Jirapanuwat S; Skulchan V; Rojananin S; Chantarakul N
    J Med Assoc Thai; 1989 Feb; 72(2):82-9. PubMed ID: 2738491
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biochemical and pharmacological effects of mitoxantrone and acetyl-L-carnitine in mice with a solid form of Ehrlich tumour.
    Niang M; Soukup T; Zivný P; Tomšík P; Bukač J; Rezáčová M; Stoklasová A; Cerman J; Sišpera L
    Chemotherapy; 2011; 57(1):35-42. PubMed ID: 21212670
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phase II study of mitoxantrone in advanced breast cancer: an Eastern Cooperative Oncology Group pilot study.
    Levin M; Pandya KJ; Khandekar JD; Horton J; Glick JH; Bennett JM; Muggia FM; Falkson G
    Cancer Treat Rep; 1984 Dec; 68(12):1511-2. PubMed ID: 6509455
    [No Abstract]   [Full Text] [Related]  

  • 39. Biological evaluation of mitoxantrone dihydrochloride synthesized by a new method. II. Comparison of Now 85/34 and Novantrone (Lederle) acute toxicity and antitumor activity.
    Matuszyk J; Kuśnierczyk H; Radzikowski C
    Arch Immunol Ther Exp (Warsz); 1989; 37(1-2):89-99. PubMed ID: 2619513
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug helps delay progression of multiple sclerosis.
    FDA Consum; 2001; 35(1):4. PubMed ID: 11930924
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.